Business of Regenerative Medicine

The Business of Regenerative Medicine: Leadership, Innovation & Entrepreneurship, is co-hosted by Centre for Commercialization of Regenerative Medicine (CCRM) and the Rotman School of Management.

This 2.5 day interactive event will include talks delivered by established scientific and industry leaders, advice from entrepreneurs, panel discussions, pitches from start-ups, case studies and networking events.

Memebers of Cell and Gene Therapy Catapult will be providing updates in the areas of regulatory affairs and reimbursement.

Tuesday 18 July, 8:40am - 10:40am -  Updates and trends with global regulatory/QSR reguirements, Dr Jacqualine Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult

Tuesday 18 July, 8:40am - 10:40am -  Reimbursement considerations for regenerative medicine, Dr Panos Kefalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult

View the full agenda on the event website.

  • FDA approves , a one-time AAV gene therapy indicated for the treatment of patients with a rare form of inh… 1 hour 5 min ago

Discover who we are